OPRM1 A118G biomarker_for alcoholism
Evidence from:
primary |
all sources
Evidence (1 sources)
Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.
(2012)
PMID:22954510
cited
may impact the application of personalized medicine approaches to optimizing naltrexone treatment for alcoholism
confidence: 0.78